A Phase II Study of Dasatinib and Dexamethasone As Primary Therapy Followed By Transplantation for Adults with Newly Diagnosed Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia (Ph plus ALL): Final Results of Alliance/CALGB Study 10701 Wieduwilt, M. J., Yin, J., Wetzler, M., Uy, G. L., Powell, B. L., Kolitz, J. E., Liedtke, M., Stock, W., Beumer, J. H., Mattison, R. J., Storrick, E., Devine, S., Smith, S. E., Stone, R. M., Larson, R. A. AMER SOC HEMATOLOGY. 2018

View details for DOI 10.1182/blood-201/1-99-120029

View details for Web of Science ID 000454837601018